Ursofalk Capsules
　＃　Ursofalk, an ursodeoxycholic acid (UDCA) capsule, is produced by Dr. Falk Pharma GmbH, Germany. Shenzhen Kangzhe Pharmaceutical Co., Ltd. has been the agent of Ursofalk with exclusive distribution right in China since 1998.

　＃　UDCA is widely used on the treatment of hepatobiliary diseases such as chronic viral hepatitis, alcoholic and non-alcoholic steatohepatitis. Ursofalk is the first choice effective medication for dissolution of cholesterol gallstones in the gallbladder when gallstones are radiolucent and the gallbladder function is intact, cholestatic liver disease (e.g. primary biliary cirrhosis), and biliary reflux gastritis. Ursofalk is included in the National Basic Insurance Drug List, under category A.

©2006 CMS，Shenzhen Kangzhe Pharmaceutical Co., Ltd. All Rights Reserved.